These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2518039)

  • 1. [Isolation and identification of the products of Streptococcus faecalis inhibiting mycelial transformation of Candida albicans].
    Kaczmarski W; Jakoniuk P; Borowski J
    Med Dosw Mikrobiol; 1989; 41(3-4):192-201. PubMed ID: 2518039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of selected bacteria on mycelial transformation of cells of Candida albicans].
    Kaczmarski W; Jakoniuk P; Borowski J
    Med Dosw Mikrobiol; 1989; 41(3-4):184-91. PubMed ID: 2518038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of itraconazole on the process of mycelial transformation of Candida albicans cells in human serum].
    Gwiezdziński Z; Urbanowski S; Nierebińska E
    Med Dosw Mikrobiol; 1989; 41(3-4):202-5. PubMed ID: 2561811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of an anti-Candida factor produced by Enterococcus faecalis.
    Shekh RM; Roy U
    BMC Microbiol; 2012 Jul; 12():132. PubMed ID: 22759735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro yeast infection of human dentin.
    Waltimo TM; Ørstavik D; Sirén EK; Haapasalo MP
    J Endod; 2000 Apr; 26(4):207-9. PubMed ID: 11199719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid differentiation of Candida albicans from other Candida species using its unique germ tube formation at 39 degrees C.
    Kim D; Shin WS; Lee KH; Kim K; Young Park J; Koh CM
    Yeast; 2002 Aug; 19(11):957-62. PubMed ID: 12125052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of Candida albicans 20S proteasome: identification of four proteasomal subunits.
    Fernández Murray P; Biscoglio MJ; Passeron S
    Arch Biochem Biophys; 2000 Mar; 375(2):211-9. PubMed ID: 10700377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of polar lipids from yeast and mycelial forms of Candida albicans and Candida dubliniensis.
    Mahmoudabadi AZ; Drucker DB
    Mycoses; 2006 Jan; 49(1):18-22. PubMed ID: 16367813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of salivary components that induce transition of hyphae to yeast in Candida albicans.
    Leito JT; Ligtenberg AJ; Nazmi K; Veerman EC
    FEMS Yeast Res; 2009 Oct; 9(7):1102-10. PubMed ID: 19799638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Candida albicans by the anaerobic oral flora of mice in vitro.
    Kennedy MJ
    Sabouraudia; 1981 Sep; 19(3):205-8. PubMed ID: 7027476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl-D-glucosamine-induced morphogenesis in Candida albicans.
    Cassone A; Sullivan PA; Shepherd MG
    Microbiologica; 1985 Jan; 8(1):85-99. PubMed ID: 3883103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activities of Candida yeasts. Partial purification and characterization of the active substance of Candida guilliermondii.
    Budak A; Sahl HG; Brandis H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):390-6. PubMed ID: 6820590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytological interrelationships between the cell cycle and duplication cycle of Candida albicans.
    Gow NA; Henderson G; Gooday GW
    Microbios; 1986; 47(191):97-105. PubMed ID: 3537639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and amino acid composition of peptide antibiotic AS-48 produced by Streptococcus (Enterococcus) faecalis subsp. liquefaciens S-48.
    Gálvez A; Giménez-Gallego G; Maqueda M; Valdivia E
    Antimicrob Agents Chemother; 1989 Apr; 33(4):437-41. PubMed ID: 2499249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraction and purification of a catalase from Candida albicans.
    Tosado-Acevedo R; Toranzos GA; Alsina A
    P R Health Sci J; 1992 Aug; 11(2):77-80. PubMed ID: 1635971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and partial purification of a broad spectrum antibiotic AS-48 produced by Streptococcus faecalis.
    Gálvez A; Maqueda M; Valdivia E; Quesada A; Montoya E
    Can J Microbiol; 1986 Oct; 32(10):765-71. PubMed ID: 3098396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple synthetic liquid medium for development of yeast and mycelial form of pathogenic species of Candida.
    Prakash P; Solanki A; Joshi KR
    Indian J Pathol Microbiol; 1997 Jan; 40(1):55-8. PubMed ID: 9145613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTA preparations from different origins may vary in their antimicrobial activity.
    Al-Hezaimi K; Al-Shalan TA; Naghshbandi J; Simon JH; Rotstein I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):e85-8. PubMed ID: 19426914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation and characteristics of surface proteins from Streptococcus group A].
    Savel'ev EP; Blinnikova EI; Bitko SA; Degtiareva OP
    Biokhimiia; 1987 Nov; 52(11):1875-80. PubMed ID: 3326638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.